S
Suellen R R Siqueira
Publications - 1
Citations - 278
Suellen R R Siqueira is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & Tocilizumab. The author has an hindex of 1, co-authored 1 publications receiving 152 citations.
Papers
More filters
Journal ArticleDOI
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial.
Viviane C Veiga,João Prats,Danielle Leão Cordeiro de Farias,Regis Goulart Rosa,Letícia K. Dourado,Fernando G. Zampieri,Flávia Ribeiro Machado,Renato D. Lopes,Otavio Berwanger,Luciano Cesar Pontes Azevedo,Alvaro Avezum,Thiago Lisboa,Salomón Soriano Ordinola Rojas,Juliana C Coelho,Rodrigo T Leite,Júlio César de Carvalho,Luis Eduardo Coelho Andrade,Alex Freire Sandes,Maria Carolina Pintao,Claudio G Castro,Sueli V Santos,Thiago Miranda Lopes de Almeida,André Nathan Costa,Otavio Gebara,Flávio Geraldo Rezende Freitas,Eduardo Souza Pacheco,David J B Machado,Josiane Martin,Fábio G Conceição,Suellen R R Siqueira,Lucas P. Damiani,Luciana M Ishihara,Daniel Schneider,Denise de Souza,Alexandre Biasi Cavalcanti,Phillip Scheinberg +35 more
TL;DR: Tocilizumab (single intravenous infusion of 8 mg/kg) plus standard care was not superior to standard care alone in improving clinical outcomes at 15 days, and it might increase mortality.